CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 802 enrolled
Drug / intervention
Best Practice +3 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04411849
NCT04411849N/ACompleted
CompareCT.gov

A Multilevel HPV Self-Testing Intervention to Increase Cervical Cancer Screening Among Women in Appalachia

Ohio State University Comprehensive Cancer Center·interventional·Posted Jun 2, 2020·Updated Sep 10, 2025

In Brief

A clinical study evaluating Best Practice, HPV Self-Collection, and 2 other interventions for Cervical Carcinoma and Human Papillomavirus Infection. Completed, enrolled 802 participants across 4 sites.

Detailed Summary

This trial studies how well a multilevel human papillomavirus (HPV) self-testing intervention works in increasing cervical cancer screening among women in Appalachia. Most cases of cervical cancer occur among unscreened and underscreened women. A multilevel HPV self-testing intervention may help to improve cervical cancer screening rates.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCervical Carcinoma, Human Papillomavirus Infection
CountriesUnited States
CollaboratorsNational Cancer Institute (NCI)

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedJun 2, 2020
Enrollment StartAug 27, 2021
Primary CompletionJun 11, 2024
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 6.1 years ago

Interventions

Best Practiceother

Receive usual care

HPV Self-Collectionprocedure

Receive HPV self-testing intervention

Informational Interventionother

Receive information about cervical cancer

Patient Navigation Programbehavioral

Receive telephone-based patient navigation